LIF Promotes Neurogenesis from Spiral Ganglion Stem Cells
Author Information
Author(s): Oshima Kazuo, Teo Dawn Tju Wei, Senn Pascal, Starlinger Veronika, Heller Stefan
Primary Institution: Stanford University School of Medicine
Hypothesis
Does leukemia inhibitory factor (LIF) increase the self-renewal capacity and differentiation of spiral ganglion stem cells?
Conclusion
LIF is effective in promoting neurogenesis and maintaining neural progenitor cells derived from spiral ganglion stem cells.
Supporting Evidence
- LIF treatment led to a dose-dependent increase in the number of neurons and glial cells.
- LIF maintained a pool of neural progenitor cells in cultures.
- LIF treatment reduced the number of apoptotic cells in cultures.
- LIF and neurotrophins BDNF and NT3 acted additively to promote neuronal survival.
Takeaway
LIF helps brain cells grow and stay healthy, which could be important for treating hearing loss.
Methodology
The study involved culturing spiral ganglion stem cells with varying concentrations of LIF and assessing the effects on cell differentiation and survival.
Limitations
The study did not explore the long-term effects of LIF treatment on cell populations.
Participant Demographics
Postnatal day 1 (P1) C57/BL6 mice were used for the experiments.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website